BOLT
Bearish signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Pulls against a bullish reading. Selling cluster — sale value, no purchase value
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Unavailable or mixed. Current ratio 3.59 · operating margin -450% — readings disagree
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Unavailable or mixed. No stored price series
VENTE TOTALE: 17 566 titres (~58 402,16 $ US)
- Insiders
- Quinn William P.
- Total bought
-
—
Avg buy (VWAP, 90d window) $3.88 vs last close —
- Total sold
-
$58,402
Avg sell (VWAP, 90d window) $3.32 vs last close —
- Last activity
- 2026-09-18
- Last synced
-
2026-09-24 10:12:43
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-18 | Nemec Sarah | Sell | 4,077 | $3.24 | $13,195 | Form 4 |
| 2026-09-18 | Quinn William P. | Sell | 9,132 | $3.24 | $29,555 | Form 4 |
| 2026-09-18 | Yonehiro Grant | Sell | 6,850 | $3.24 | $22,169 | Form 4 |
| 2026-09-17 | Nemec Sarah | Sell | 2,922 | $3.32 | $9,696 | Form 4 |
| 2026-09-17 | Quinn William P. | Sell | 6,545 | $3.32 | $21,718 | Form 4 |
| 2026-09-17 | Yonehiro Grant | Sell | 4,909 | $3.32 | $16,290 | Form 4 |
| 2026-09-16 | Nemec Sarah | Sell | 843 | $3.77 | $3,181 | Form 4 |
| 2026-09-16 | Quinn William P. | Sell | 1,889 | $3.77 | $7,129 | Form 4 |
| 2026-09-16 | Yonehiro Grant | Sell | 1,417 | $3.77 | $5,348 | Form 4 |
| 2026-06-05 | Nemec Sarah | Buy | 509 | $3.88 | $1,973 | Form 4 |
| 2026-06-05 | Quinn William P. | Buy | 637 | $3.88 | $2,469 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bearish signalScored 2026-09-22
BOLT presents a deeply distressed financial profile with a liquidity score of 45 and a near-zero catalyst score of 5, reflecting severe fundamental deterioration and a complete absence of positive event-driven triggers.
The first sentence of the analysis written for BOLT on 2026-09-22 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 80.6% | 100.0% | -681.4% | -1176.4% | -5904.4% | |
| Ebit Margin | -433.7% | -887.3% | -878.6% | -1537.8% | -7824.7% | |
| Ebitda Margin | -414.4% | -864.2% | -855.0% | -1508.7% | -7730.0% | |
| Operating Profit Margin | -450.1% | -949.9% | -967.4% | -1576.6% | -7364.1% | |
| Pretax Profit Margin | -433.7% | -820.8% | -878.6% | -1537.8% | -7824.7% | |
| Continuous Operations Profit Margin | -433.7% | -820.8% | -878.6% | -1537.8% | -7824.7% | |
| Net Profit Margin | -433.7% | -820.8% | -878.6% | -1537.8% | -7824.7% | |
| Bottom Line Profit Margin | -433.7% | -820.8% | -878.6% | -1537.8% | -7824.7% | |
| Current Ratio | 3.587 | 3.205 | 5.168 | 7.472 | 8.869 | |
| Quick Ratio | 3.587 | 3.205 | 5.168 | 7.472 | 8.869 | |
| Solvency Ratio | -1.054 | -1.445 | -1.432 | -1.535 | -1.691 | |
| Cash Ratio | 1.387 | 0.454 | 0.528 | 0.400 | 1.284 | |
| Price To Earnings Ratio | -0.306 | -6.485 | -12.240 | -11.304 | -35.125 | |
| Price To Earnings Growth Ratio | -0.000 | 0.659 | 0.599 | 0.644 | -0.874 | |
| Forward Price To Earnings Growth Ratio | -0.000 | 0.659 | 0.599 | 0.644 | -0.874 | |
| Price To Earnings Diluted Ratio | -0.306 | -6.485 | -12.240 | -11.304 | -35.125 | |
| Price To Earnings Diluted Growth Ratio | -0.000 | 0.659 | 0.599 | 0.644 | -0.874 | |
| Price To Book Ratio | 0.386 | 0.357 | 0.376 | 0.283 | 0.733 | |
| Price To Sales Ratio | 1.329 | 2.656 | 5.377 | 8.477 | 145.443 | |
| Price To Free Cash Flow Ratio | -0.256 | -0.333 | -0.607 | -0.619 | -3.085 | |
| Price To Operating Cash Flow Ratio | -0.257 | -0.333 | -0.609 | -0.635 | -3.211 | |
| Debt To Assets Ratio | 0.405 | 0.253 | 0.127 | 0.099 | 0.079 | |
| Debt To Equity Ratio | 0.866 | 0.441 | 0.179 | 0.132 | 0.097 | |
| Debt To Capital Ratio | 0.464 | 0.306 | 0.152 | 0.116 | 0.089 | |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 2.141 | 1.742 | 1.417 | 1.328 | 1.230 | |
| Working Capital Turnover Ratio | 0.271 | 0.128 | 0.067 | 0.036 | 0.014 | |
| Operating Cash Flow Ratio | -4.724 | -3.865 | -3.399 | -3.309 | -2.676 | |
| Operating Cash Flow Sales Ratio | -5.179 | -7.970 | -8.827 | -13.354 | -45.290 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.002 | 1.001 | 1.003 | 1.026 | 1.041 | |
| Debt Service Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | -38.944 | |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | -22.817 | |
| Operating Cash Flow Coverage Ratio | -1.736 | -2.431 | -3.439 | -3.383 | -2.343 | |
| Capital Expenditure Coverage Ratio | -553.472 | -1,494.854 | -337.500 | -39.173 | -24.408 | |
| Dividend Paid And Capex Coverage Ratio | -553.472 | -1,494.854 | -337.500 | -39.173 | -24.408 | |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Enterprise Value Multiple | -0.674 | -0.578 | -0.769 | -0.717 | -1.850 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 80.6% | ▼-19.4% | ▲1596.9% |
| Ebit Margin | -433.7% | ▲453.6% | ▲1878.7% |
| Ebitda Margin | -414.4% | ▲449.8% | ▲1860.1% |
| Operating Profit Margin | -450.1% | ▲499.8% | ▲1811.6% |
| Pretax Profit Margin | -433.7% | ▲387.0% | ▲1865.4% |
| Continuous Operations Profit Margin | -433.7% | ▲387.0% | ▲1865.4% |
| Net Profit Margin | -433.7% | ▲387.0% | ▲1865.4% |
| Bottom Line Profit Margin | -433.7% | ▲387.0% | ▲1865.4% |
| Current Ratio | 3.587 | ▲0.383 | ▼-2.073 |
| Quick Ratio | 3.587 | ▲0.383 | ▼-2.073 |
| Solvency Ratio | -1.054 | ▲0.391 | ▲0.377 |
| Cash Ratio | 1.387 | ▲0.933 | ▲0.577 |
| Price To Earnings Ratio | -0.306 | ▲6.178 | ▲12.786 |
| Price To Earnings Growth Ratio | -0.000 | ▼-0.660 | ▼-0.206 |
| Forward Price To Earnings Growth Ratio | -0.000 | ▼-0.660 | ▼-0.206 |
| Price To Earnings Diluted Ratio | -0.306 | ▲6.178 | ▲12.786 |
| Price To Earnings Diluted Growth Ratio | -0.000 | ▼-0.660 | ▼-0.206 |
| Price To Book Ratio | 0.386 | ▲0.029 | ▼-0.041 |
| Price To Sales Ratio | 1.329 | ▼-1.327 | ▼-31.327 |
| Price To Free Cash Flow Ratio | -0.256 | ▲0.077 | ▲0.724 |
| Price To Operating Cash Flow Ratio | -0.257 | ▲0.077 | ▲0.752 |
| Debt To Assets Ratio | 0.405 | ▲0.151 | ▲0.212 |
| Debt To Equity Ratio | 0.866 | ▲0.425 | ▲0.523 |
| Debt To Capital Ratio | 0.464 | ▲0.158 | ▲0.239 |
| Long Term Debt To Capital Ratio | 0.000 | 0.000 | 0.000 |
| Financial Leverage Ratio | 2.141 | ▲0.399 | ▲0.569 |
| Working Capital Turnover Ratio | 0.271 | ▲0.143 | ▲0.168 |
| Operating Cash Flow Ratio | -4.724 | ▼-0.859 | ▼-1.130 |
| Operating Cash Flow Sales Ratio | -5.179 | ▲2.791 | ▲10.945 |
| Free Cash Flow Operating Cash Flow Ratio | 1.002 | ▲0.001 | ▼-0.013 |
| Debt Service Coverage Ratio | 0.000 | 0.000 | ▲7.789 |
| Interest Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | ▲4.564 |
| Operating Cash Flow Coverage Ratio | -1.736 | ▲0.696 | ▲0.931 |
| Capital Expenditure Coverage Ratio | -553.472 | ▲941.381 | ▼-63.591 |
| Dividend Paid And Capex Coverage Ratio | -553.472 | ▲941.381 | ▼-63.591 |
| Dividend Payout Ratio | 0.000 | 0.000 | 0.000 |
| Enterprise Value Multiple | -0.674 | ▼-0.096 | ▲0.244 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $10.2M | $20.4M | $42.3M | $48.6M | $183.3M | |
| Enterprise value | $21.5M | $38.4M | $51.8M | $61.9M | $180.2M | |
| EV / Sales | 2.79x | 5.00x | 6.57x | 10.81x | 143.04x | |
| EV / Op. cash flow | -0.54x | -0.63x | -0.74x | -0.81x | -3.16x | |
| EV / Free cash flow | -0.54x | -0.63x | -0.74x | -0.79x | -3.03x | |
| EV / EBITDA | -0.67x | -0.58x | -0.77x | -0.72x | -1.85x | |
| Net debt / EBITDA | -0.35x | -0.27x | -0.14x | -0.15x | 0.03x | |
| Current ratio | 3.59x | 3.21x | 5.17x | 7.47x | 8.87x | |
| Income quality | 1.19x | 0.97x | 1.00x | 0.87x | 0.58x | |
| Graham net-net | -$1 | $3 | $29 | $60 | $69 | |
| Tax burden | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| Interest burden | 100.0% | 92.5% | 100.0% | 100.0% | 100.0% | |
| Working capital | $21.8M | $35.0M | $85.3M | $149.6M | $167.8M | |
| Invested capital | $42.3M | $59.9M | $109.3M | $178.2M | $198.4M | |
| Return on assets | -58.8% | -63.4% | -43.3% | -38.7% | -32.0% | |
| Operating ROA | -44.3% | -56.3% | -39.3% | -33.7% | -52.4% | |
| Return on tangible assets | -58.8% | -63.4% | -43.3% | -38.7% | -32.0% | |
| Return on equity | -125.9% | -110.4% | -61.4% | -51.4% | -39.4% | |
| Return on invested capital | -67.7% | -84.9% | -53.6% | -43.6% | -32.1% | |
| Return on capital employed | -71.7% | -87.2% | -54.7% | -44.1% | -32.4% | |
| Earnings yield | -326.3% | -309.0% | -163.4% | -181.4% | -53.8% | |
| Free cash flow yield | -390.3% | -300.2% | -164.7% | -161.5% | -32.4% | |
| Capex / Op. cash flow | -0.2% | -0.1% | -0.3% | -2.6% | -4.1% | |
| Capex / Depreciation | 5.6% | 2.3% | 11.1% | 117.2% | 196.0% | |
| Capex / Sales | 0.9% | 0.5% | 2.6% | 34.1% | 185.6% | |
| SG&A / Sales | 179.3% | 240.0% | 286.1% | 400.2% | 1459.8% | |
| R&D / Sales | 370.8% | 747.3% | 781.4% | 1276.4% | 6004.4% | |
| Stock comp / Sales | 36.2% | 96.3% | 117.1% | 167.1% | 674.6% | |
| Intangibles / Total assets | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| Days sales outstanding | 46d | 55d | 0d | 0d | 58d | |
| Days payables outstanding | 353d | 0d | 18d | 18d | 17d | |
| Operating cycle | 46d | 55d | 0d | 0d | 58d | |
| Cash conversion cycle | -307d | 55d | -18d | -18d | 41d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▼-49.9%EV / Sales ▼-44.1%EV / EBITDA ▼-16.5%EV / Op. cash flow ▲+0.088Earnings yield ▼-0.173
Profitability
Return on equity ▼-0.156Return on assets ▲+0.045Return on invested capital ▲+0.172Return on capital employed ▲+0.155Operating ROA ▲+0.120Income quality ▲+0.223Tax burden 0.000
Efficiency
Days sales outstanding ▼-9.143Days payables outstanding n/aOperating cycle ▼-9.143Cash conversion cycle ▼-362.393Capex / Sales ▲+0.004R&D / Sales ▼-3.765
Balance-sheet strength
Current ratio ▲+0.383Net debt / EBITDA ▼-0.082Working capital ▼-13133000.000Invested capital ▼-17553000.000Intangibles / Total assets n/a
Change over 5 years
Valuation
Market cap ▼-94.4%EV / Sales ▼-98.0%EV / EBITDA ▲+63.6%EV / Op. cash flow ▲+2.619Earnings yield ▼-2.725
Profitability
Return on equity ▼-0.865Return on assets ▼-0.268Return on invested capital ▼-0.356Return on capital employed ▼-0.393Operating ROA ▲+0.081Income quality ▲+0.615Tax burden 0.000
Efficiency
Days sales outstanding ▼-11.784Days payables outstanding ▲+336.007Operating cycle ▼-11.784Cash conversion cycle ▼-347.790Capex / Sales ▼-1.846R&D / Sales ▼-56.336
Balance-sheet strength
Current ratio ▼-5.282Net debt / EBITDA ▼-0.384Working capital ▼-146007000.000Invested capital ▼-156135000.000Intangibles / Total assets n/a
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent news
- 2026-09-22 Bolt Biotherapeutics (NASDAQ:BOLT) VP Sarah Nemec Sells 4,077 Shares Bolt Biotherapeutics, Inc. (NASDAQ: BOLT - Get Free Report) VP Sarah Nemec sold 4,077 shares of Bolt Biotherapeutics stock in a transaction on Friday, September 18th. The shares were sold at an average price of $3.24, for a total value of $13,209.48. Following the completion of the transaction, the vice president owned 17,082 shares of the
- 2026-09-22 Bolt Biotherapeutics (NASDAQ:BOLT) COO Grant Yonehiro Sells 4,909 Shares of Stock Bolt Biotherapeutics, Inc. (NASDAQ: BOLT - Get Free Report) COO Grant Yonehiro sold 4,909 shares of the firm''s stock in a transaction that occurred on Thursday, September 17th. The stock was sold at an average price of $3.32, for a total transaction of $16,297.88. Following the completion of the transaction, the chief operating officer directly owned
- 2026-08-11 Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Misses Revenue Estimates Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $4.57 per share versus the Zacks Consensus Estimate of a loss of $2.97. This compares to a loss of $4.46 per share a year ago.
- 2026-08-11 Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update First-in-class immune-stimulating antibody conjugate BDC-4182 Phase 1/2 study ongoing, initial clinical data expected to be released with Bolt''s 3Q 2026 results Cash balance of $18.1 million as of June 30, 2026 anticipated to fund operations into 1Q 2027 REDWOOD CITY, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today reported financial results for the second quarter ended June 30, 2026, and provided a business update.